Table 2.
Summary of effects of PUFA analogues on the cardiac IKs channel
PUFA nameI/I0ΔV0.5 (mV)Gmax/Gmax0n
Linoleic acid 0.5 ± 0.04 4.7 ± 0.9 0.7 ± 0.04 
Lin-glycine 5.3 ± 0.5 −26.4 ± 4.4 2.4 ± 0.2 
Lin-taurine 10.4 ± 4.0 −73.1 ± 2.6 2.0 ± 0.6 
Lin-glycine+1C 1.7 ± 0.2 −7.2 ± 2.5 1.3 ± 0.02 
Lin-glycine+2C 1.9 ± 0.4 −8.7 ± 0.5 1.1 ± 0.2 
Lin-cysteic acid 9.2 ± 0.4 −58.4 ± 2.8 2.0 ± 0.2 
Lin-aspartate 4.0 ± 0.1 −34.5 ± 2.3 1.4 ± 0.1 
Lin-AP3 1.8 ± 0.3 −5.7 ± 1.3 1.1 ± 0.1 
DHA 2.0 ± 0.6 0.1 ± 1.4 1.7 ± 0.3 
DHA-glycine 4.7 ± 1.3 −16.5 ± 1.3 2.0 ± 0.2 
DHA-taurine 5.1 ± 0.7 −45.3 ± 2.9 1.7 ± 0.1 
Pinolenic acid 1.5 ± 0.3 −6 ± 1.8 1.4 ± 0.2 
Pin-glycine 3.8 ± 0.2 −21.1 ± 2.5 1.8 ± 0.1 
Pin-taurine 9.0 ± 1.4 51.6 ± 3.5 1.9 ± 0.3 
PUFA nameI/I0ΔV0.5 (mV)Gmax/Gmax0n
Linoleic acid 0.5 ± 0.04 4.7 ± 0.9 0.7 ± 0.04 
Lin-glycine 5.3 ± 0.5 −26.4 ± 4.4 2.4 ± 0.2 
Lin-taurine 10.4 ± 4.0 −73.1 ± 2.6 2.0 ± 0.6 
Lin-glycine+1C 1.7 ± 0.2 −7.2 ± 2.5 1.3 ± 0.02 
Lin-glycine+2C 1.9 ± 0.4 −8.7 ± 0.5 1.1 ± 0.2 
Lin-cysteic acid 9.2 ± 0.4 −58.4 ± 2.8 2.0 ± 0.2 
Lin-aspartate 4.0 ± 0.1 −34.5 ± 2.3 1.4 ± 0.1 
Lin-AP3 1.8 ± 0.3 −5.7 ± 1.3 1.1 ± 0.1 
DHA 2.0 ± 0.6 0.1 ± 1.4 1.7 ± 0.3 
DHA-glycine 4.7 ± 1.3 −16.5 ± 1.3 2.0 ± 0.2 
DHA-taurine 5.1 ± 0.7 −45.3 ± 2.9 1.7 ± 0.1 
Pinolenic acid 1.5 ± 0.3 −6 ± 1.8 1.4 ± 0.2 
Pin-glycine 3.8 ± 0.2 −21.1 ± 2.5 1.8 ± 0.1 
Pin-taurine 9.0 ± 1.4 51.6 ± 3.5 1.9 ± 0.3 

Summary of the effects of PUFAs on IKs I/I0, ΔV0.5 (mV), and Gmax/Gmax0 with the number of experiments (n). Data are represented as mean ± SEM at the maximum concentration used (effects of DHA-taurine are reported at 7 µM due to a decrease in current observed at 20 µM).

or Create an Account

Close Modal
Close Modal